Literature DB >> 23588900

Impact of providing fee data on laboratory test ordering: a controlled clinical trial.

Leonard S Feldman1, Hasan M Shihab, David Thiemann, Hsin-Chieh Yeh, Margaret Ardolino, Steven Mandell, Daniel J Brotman.   

Abstract

IMPORTANCE: Inpatient care providers often order laboratory tests without any appreciation for the costs of the tests.
OBJECTIVE: To determine whether we could decrease the number of laboratory tests ordered by presenting providers with test fees at the time of order entry in a tertiary care hospital, without adding extra steps to the ordering process.
DESIGN: Controlled clinical trial.
SETTING: Tertiary care hospital. PARTICIPANTS: All providers, including physicians and nonphysicians, who ordered laboratory tests through the computerized provider order entry system at The Johns Hopkins Hospital. INTERVENTION: We randomly assigned 61 diagnostic laboratory tests to an "active" arm (fee displayed) or to a control arm (fee not displayed). During a 6-month baseline period (November 10, 2008, through May 9, 2009), we did not display any fee data. During a 6-month intervention period 1 year later (November 10, 2009, through May 9, 2010), we displayed fees, based on the Medicare allowable fee, for active tests only. MAIN OUTCOME MEASURES: We examined changes in the total number of orders placed, the frequency of ordered tests (per patient-day), and total charges associated with the orders according to the time period (baseline vs intervention period) and by study group (active test vs control).
RESULTS: For the active arm tests, rates of test ordering were reduced from 3.72 tests per patient-day in the baseline period to 3.40 tests per patient-day in the intervention period (8.59% decrease; 95% CI, -8.99% to -8.19%). For control arm tests, ordering increased from 1.15 to 1.22 tests per patient-day from the baseline period to the intervention period (5.64% increase; 95% CI, 4.90% to 6.39%) (P < .001 for difference over time between active and control tests). CONCLUSIONS AND RELEVANCE: Presenting fee data to providers at the time of order entry resulted in a modest decrease in test ordering. Adoption of this intervention may reduce the number of inappropriately ordered diagnostic tests.

Entities:  

Mesh:

Year:  2013        PMID: 23588900     DOI: 10.1001/jamainternmed.2013.232

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  55 in total

1.  Add to cart?

Authors:  Ilona Hale
Journal:  Can Fam Physician       Date:  2015-11       Impact factor: 3.275

2.  Should cost considerations be included in medical decisions? Not so sure….

Authors:  Maurizia Capuzzo; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2015-07-28       Impact factor: 17.440

3.  Overcoming barriers to discussing out-of-pocket costs with patients.

Authors:  Kevin R Riggs; Peter A Ubel
Journal:  JAMA Intern Med       Date:  2014-06       Impact factor: 21.873

4.  Cost awareness of physicians in intensive care units: a multicentric national study.

Authors:  Romain Hernu; Martin Cour; Sylvie de la Salle; Dominique Robert; Laurent Argaud
Journal:  Intensive Care Med       Date:  2015-05-22       Impact factor: 17.440

5.  Rational test ordering in family medicine.

Authors:  Simon Morgan; Mieke van Driel; Justin Coleman; Parker Magin
Journal:  Can Fam Physician       Date:  2015-06       Impact factor: 3.275

6.  Role-Modeling Cost-Conscious Care--A National Evaluation of Perceptions of Faculty at Teaching Hospitals in the United States.

Authors:  Mitesh S Patel; Darcy A Reed; Cynthia Smith; Vineet M Arora
Journal:  J Gen Intern Med       Date:  2015-09       Impact factor: 5.128

Review 7.  The effect of charge display on cost of care and physician practice behaviors: a systematic review.

Authors:  Celine Goetz; Stephen R Rotman; George Hartoularos; Tara F Bishop
Journal:  J Gen Intern Med       Date:  2015-02-18       Impact factor: 5.128

8.  Incorporating value into physician payment and patient cost sharing.

Authors:  Zirui Song; Amol S Navathe; Ezekiel J Emanuel; Kevin G Volpp
Journal:  Am J Manag Care       Date:  2018-03       Impact factor: 2.229

9.  Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests: The PRICE Randomized Clinical Trial.

Authors:  Mina S Sedrak; Jennifer S Myers; Dylan S Small; Irving Nachamkin; Justin B Ziemba; Dana Murray; Gregory W Kurtzman; Jingsan Zhu; Wenli Wang; Deborah Mincarelli; Daniel Danoski; Brian P Wells; Jeffrey S Berns; Patrick J Brennan; C William Hanson; C Jessica Dine; Mitesh S Patel
Journal:  JAMA Intern Med       Date:  2017-07-01       Impact factor: 21.873

10.  How Primary Care Physicians Integrate Price Information into Clinical Decision-Making.

Authors:  Katherine H Schiavoni; Lisa Soleymani Lehmann; Wendy Guan; Meredith Rosenthal; Thomas D Sequist; Alyna T Chien
Journal:  J Gen Intern Med       Date:  2016-08-25       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.